Day One Biopharmaceuticals, Inc.Day One Biopharmaceuticals, Inc.Day One Biopharmaceuticals, Inc.

Day One Biopharmaceuticals, Inc.

No trades
See on Supercharts

DAWN fundamentals

Day One Biopharmaceuticals, Inc. earnings per share and revenue

DAWN earnings per share for the last quarter are 0.38 USD whereas the estimation was -0.32 USD which accounts for 220.42% surprise. Company revenue for the same period amounts to 93.76 M USD despite the estimated figure of 28.48 M USD. Estimated earnings per share for the next quarter are -0.46 USD, and revenue is expected to reach 27.18 M USD. Also watch annual changes over time to get a bigger picture of DAWN earnings per share and revenue dynamics.

Next report date
Report period
EPS estimate
Revenue estimate
EPS
‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Revenue
‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise